Cardiosphere-derived cells for the treatment of myocardial infarction
This study aims to determine whether allogeneic cardiosphere-derived cells (CAP-1002) are safe and effective in decreasing infarct size in patients with myocardial infarction.
Read More
Product Information for
Cardiosphere-derived cells for the treatment of myocardial infarction
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access